These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14222016)

  • 21. [OBSERVATIONS ON THE CULTURE OF POLIOVIRUS STRAINS FROM THE BLOOD AFTER VACCINATION WITH SABIN VACCINE L SC 2 AB].
    GRUETZNER L
    Zentralbl Bakteriol Orig; 1963 Dec; 191():90-1. PubMed ID: 14119947
    [No Abstract]   [Full Text] [Related]  

  • 22. ANTIBODY RESPONSE TO TYPE 1 ORAL POLIO VACCINE.
    PETERSEN I; VONMAGNUS H
    Acta Pathol Microbiol Scand; 1964; 62():331-9. PubMed ID: 14227876
    [No Abstract]   [Full Text] [Related]  

  • 23. POLIOVIRUS IN FEBRILE VACCINEES.
    KELLY S; FOX JP; SPIGLAND I
    Arch Environ Health; 1965 Jan; 10():16-20. PubMed ID: 14219480
    [No Abstract]   [Full Text] [Related]  

  • 24. [ON HETEROLOGOUS ANTIBODY FORMATION AFTER ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Z Immunitats Allergieforsch; 1964 Jul; 127():64-74. PubMed ID: 14259857
    [No Abstract]   [Full Text] [Related]  

  • 25. [DETECTION OF ANTIBODIES TO MONKEY VIRUS (OB40) IN HUMAN SERA. SEROLOGICAL EVIDENCE OF INFECTION FROM MONKEYS AND KIDNEY CULTURES].
    CHUMAKOVA MIa; CHUMAKOV MP; ELBERT LB; AVGUSTINOVICH GI; RALF NM; VOROSHILOVA MK; TARANOVA GP; TAPUPERE VO
    Vopr Virusol; 1963; 29():457-60. PubMed ID: 14071285
    [No Abstract]   [Full Text] [Related]  

  • 26. [STUDIES ON INJECTIONS OF WEAK LIVE POLIOVIRUS VACCINE INTO CHILDREN. 3. RESULTS OF QUANTITATIVE CULTURE OF VIRUS FROM FECES OF CHILDREN GIVEN LIVE VACCINE].
    KAMIYA K
    Nihon Shonika Gakkai Zasshi; 1963 Oct; 67():714-7. PubMed ID: 14093741
    [No Abstract]   [Full Text] [Related]  

  • 27. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 28. REVERSIBLE INHIBITION OF POLIOVIRUS RIBONUCLEIC ACID.
    ENGLER R; TOLBERT O
    Arch Gesamte Virusforsch; 1963 Aug; 13():470-81. PubMed ID: 14078838
    [No Abstract]   [Full Text] [Related]  

  • 29. REACTION OF POLIOVIRUS AND FORMALDEHYDE IN MAGNESIUM CHLORIDE SOLUTION TO ENHANCE POTENCY OF KILLED-VIRUS VACCINE.
    OZAKI Y; MELNICK JL
    J Immunol; 1963 Mar; 90():429-37. PubMed ID: 14051877
    [No Abstract]   [Full Text] [Related]  

  • 30. POLIOVIRUS SHEDDING AND SEROCONVERSION. STUDIES OF 816 COSTA RICAN CHILDREN FED TRIVALENT VACCINE.
    ROCA-GARCIA M; MARKHAM FS; COX HR; VARGAS-MENDEZ O; GUEVARA EC; MONTOYA JA
    JAMA; 1964 May; 188():639-46. PubMed ID: 14121285
    [No Abstract]   [Full Text] [Related]  

  • 31. DEXTRAN SULFATE PLAQUE VARIANTS OF ATTENUATED TYPE 1 POLIOVIRUS. RELATIONSHIP TO IN VITRO AND IN VIVO MARKERS.
    TAKEMOTO KK; KIRSCHSTEIN RL
    J Immunol; 1964 Feb; 92():329-33. PubMed ID: 14160455
    [No Abstract]   [Full Text] [Related]  

  • 32. [PECULIARITIES IN VIRUS EXCRETION AND ANTIBODY FORMATION AFTER ADMINISTRATION OF A "BALANCED" LIVE VACCINE MIXTURE OF POLIOVIRUS TYPES I AND II].
    HENIGST W; MUELLER F; WUERSCHING F
    Z Hyg Infektionskr; 1963 Dec; 149():383-400. PubMed ID: 14123271
    [No Abstract]   [Full Text] [Related]  

  • 33. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 34. [RESEARCH "IN VITRO" ON THE ANTIPOLIOMYELITIC ACTIVITY OF GUANIDINE AND ON ITS CAPACITY TO INDURE A GUANIDINE-DEPENDENCE OF THE VIRUS].
    BROTZU G; FERRARI W; LODDO B; SPANEDDA A
    G Ital Chemioter; 1963; 10():1-23. PubMed ID: 14079388
    [No Abstract]   [Full Text] [Related]  

  • 35. THE STABILIZING EFFECT OF L-CYSTINE ON THE THERMAL INACTIVATION OF POLIOVIRUS. I. DIFFERENTIATION OF THE STRAINS OF POLIOVIRUS BY HEATING WITH L-CYSTINE.
    IKEGAMI N; YOSHIKAWA E; TAGAYA I
    Jpn J Med Sci Biol; 1963 Dec; 16():325-42. PubMed ID: 14130752
    [No Abstract]   [Full Text] [Related]  

  • 36. EPIDEMIOLOGICAL ASPECTS OF COXSACKIE AND ECHO VIRUS INFECTIONS IN TROPICAL AREAS.
    FOX JP
    Am J Public Health Nations Health; 1964 Jul; 54(7):1134-42. PubMed ID: 14157847
    [No Abstract]   [Full Text] [Related]  

  • 37. A COMPARISON OF THE REACTIVITY OF POLIOVIRUS COMPLEMENT-FIXING ANTIGENS (NATIVE, HEATED AND SUCROSE DENSITY GRADIENT C AND D) WITH HUMAN SERA.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL; HAGENS SJ; DUKELLIS EJ
    J Immunol; 1964 Feb; 92():261-74. PubMed ID: 14160447
    [No Abstract]   [Full Text] [Related]  

  • 38. A SERUM INHIBITOR IN ANIMAL AND HUMAN SERA OF BOVINE ENTEROVIRUSES. II. IN VIVO ACTIVITY AND ROLE IN "NATURAL" RESISTANCE TO INFECTION.
    KLEIN M; DEFOREST A
    J Immunol; 1964 May; 92():822-6. PubMed ID: 14170425
    [No Abstract]   [Full Text] [Related]  

  • 39. ELECTRON MICROSCOPIC STUDY OF THE FORMATION OF POLIOVIRUS.
    DALES S; EGGERS HJ; TAMM I; PALADE GE
    Virology; 1965 Jul; 26():379-89. PubMed ID: 14319710
    [No Abstract]   [Full Text] [Related]  

  • 40. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.